UBS Group’s Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share VHAQ.WS Stock Holding History

UBS Group’s Portfolio VHAQ.WS Stock Details VHAQ.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-50	Closed	-$1	–	10502
2023 Q3	$1	Sell	50 -4,287	-99%	-$92	﹤0.01%	9396
2023 Q2	$87	Sell	4,337 -12,920	-75%	-$345	﹤0.01%	8530
2023 Q1	$259	Sell	17,257 -1,020	-6%	-$30	﹤0.01%	9110
2022 Q4	$914	Buy	18,277 +12,867	+238%	+$705	﹤0.01%	10035
2022 Q3	$0	Sell	5,410 -100	-2%	-$7	﹤0.01%	11308
2022 Q2	$0	Buy	5,510 +3,591	+187%	+$273	﹤0.01%	11306
2022 Q1	$0	Sell	1,919 -6,707	-78%	-$858	﹤0.01%	11219
2021 Q4	$2K	Buy	8,626 +6,600	+326%	+$1.79K	﹤0.01%	9872
2021 Q3	$1K	Buy	+2,026	New	+$618	﹤0.01%	9326

Other funds holding VHAQ.WS

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

UBS Group's VHAQ.WS Position: Q4 2023 in Review

UBS Group sold out of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) in Q4 2023, closing a stake of 50 shares — an estimated $1 sold.

UBS Group first reported a position in VHAQ.WS in Q3 2021 and held it in 9 quarters. The position peaked at $2K in Q4 2021. 6 funds tracked by Wall St. Rank hold VHAQ.WS as of Q4 2023.

UBS Group reported no remaining Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position as of Q4 2023 after selling out during the quarter.
UBS Group sold 50 Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share shares in Q4 2023, an estimated $1.
UBS Group first reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in Q3 2021 and held it in 9 quarters.
UBS Group's Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position peaked at $2K in Q4 2021.
6 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.